The international conference brings together leading researchers, clinicians, healthcare professionals and industry experts to explore the development, application and clinical translation of digital biomarkers.
Digital biomarkers are transforming how health and disease can be measured, monitored and understood. The conference will examine emerging technologies that enable continuous and personalized health assessment, including wearable sensors, implantable devices, remote monitoring technologies and data-driven health platforms.
A central focus will be the integration of artificial intelligence and advanced data analytics into digital biomarker research. Experts will explore how large-scale health data can support earlier detection, clinical decision-making, personalized medicine and improved patient monitoring. The programme will also address the challenges involved in validating digital biomarkers across different diseases and populations.
The conference places particular emphasis on the transition from technological innovation to real-world clinical implementation. Discussions will consider how digital biomarkers can be integrated into clinical workflows, healthcare systems and evidence-based medical practice. Regulatory, ethical and practical questions surrounding the adoption of new digital health technologies will also be examined.
Another important theme is the responsible use of digital health data. Issues including ethical governance, privacy, patient acceptance and sociocultural factors are increasingly important as wearable and connected technologies become part of everyday healthcare. The conference provides a forum for discussing how innovation can be combined with trust, safety and responsible implementation.
The Nature Conference: Digital Biomarkers 2027 is particularly relevant to researchers in biomedical engineering, digital health, medicine, data science and related disciplines, as well as healthcare organizations, technology companies and innovators developing next-generation monitoring and diagnostic solutions. The event is organized in close collaboration with leading academic and medical institutions, including Charité – Universitätsmedizin Berlin.
Hosted at ETH Zürich, the conference offers an international platform for scientific exchange, networking and collaboration at the intersection of medicine, technology and data science. With its focus on wearable technologies, AI, clinical translation and responsible digital health, Digital Biomarkers 2027 provides a forward-looking view of how emerging technologies are changing the measurement and delivery of healthcare.
